CAG regimen for refractory or relapsed adult T‐cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort study

Adult patients with relapsed or refractory T‐cell acute lymphoblastic leukemia (R/R‐T‐ALL) have extremely poor prognosis, representing an urgent unmet medical need. Finding an optimal salvage regimen to bridge transplantation is a priority. The CAG (cytarabine, aclarubicin, and G‐CSF) regimen was in...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Jie‐Jing, Hu, Xiaoxia, Wang, Ying, Zhang, Yi, Du, Juan, Yang, Min, Tong, Hongyan, Qian, Wen‐Bin, Wei, Juying, Yu, Wenjun, Lou, Yin‐Jun, Mao, Liping, Tao Meng, Hai, You, Liang‐Shun, Wang, Libing, Li, Xia, Huang, Xin, Cao, Li‐Hong, Zhao, Jian‐Zhi, Yan Yan, Xiao, Chen, Yu‐Bao, Chen, Yu, Zhang, Su‐Jiang, Jin, Jie, Hu, Jiong, Zhu, Hong‐Hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402818/
https://www.ncbi.nlm.nih.gov/pubmed/32492289
http://dx.doi.org/10.1002/cam4.3079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402818/
https://www.ncbi.nlm.nih.gov/pubmed/32492289
http://dx.doi.org/10.1002/cam4.3079

Ejemplares similares